Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: A two-year study

Journal of the Neurological Sciences

Volumn 308, Issue 1-2, 2011, Pages 124-127

  Rajabally, Yusuf A ^a   Kearney, David A ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Guillain Barr Syndrome; Intravenous immunoglobulins; Multifocal motor neuropathy; Side effects; Thromboembolic complications

Indexed keywords

IMMUNOGLOBULIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DOSE RESPONSE; FEMALE; GUILLAIN BARRE SYNDROME; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIFOCAL MOTOR NEUROPAHTY; MULTIFOCAL MOTOR NEUROPATHY; NEUROPATHY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; POLYNEUROPATHIES; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 80051581746     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.05.035     Document Type: Article

References (18)

1. S. Jacob, and Y.A. Rajabally Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies Curr Neuropharmacol 7 2009 337 342
2. M. Stangel, H.P. Hartung, P. Marx, and R. Gold Side effects of high-dose intravenous immunoglobulins Clin Neuropharmacol 20 1997 385 393
3. P.D. Donofrio, V. Bril, M.C. Dalakas, C. Deng, K. Hanna, and H.P. Hartung IGIV-C CIDP Efficacy (ICE) Study Group Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy Arch Neurol 67 2010 1082 1088
4. M.M. Eibi Intravenous immunoglobulins in neurological disorders: safety issues Neurol Sci S4 2003 222 226
5. M. Stangel, R. Kiefer, M. Pette, M.N. Smolka, P. Marx, and R. Gold Side effects of intravenous immunoglobulins in neurological autoimmune disorders - a prospective study J Neurol 250 2003 818 821
6. M. Wittstock, R. Benecke, and K. Zettl Therapy with intravenous immunoglobulins: complications and side-effects Eur Neurol 50 2003 172 175
7. M.C. Dalakas High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events Neurology 44 1994 223 226
8. I. Marie, G. Maurey, F. Hervé, M.F. Hellot, and H. Levesque Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature Br J Dermatol 155 2006 714 721
9. J.B. Caress, M.S. Cartwright, P.D. Donofrio, and J.E. Peacock The clinical features of 16 cases of stroke associated with administration of IVIg Neurology 60 2003 1822 1824
10. J.B. Caress, L. Hobson-Webb, L.V. Passmore, A.P. Finkbiner, and M.S. Cartwright Case-control study of thromboembolic events associated with IV immunoglobulin J Neurol 256 2009 339 342
11. H. Orbach, U. Katz, Y. Sherer, and Y. Schoenfeld Intravenous immunoglobulin: adverse effects and safe administration Clin Rev Allergy Immunol 29 2005 173 184
12. J.C. Cleland, K. Malik, P. Thaisetthawatkul, D.N. Herrmann, and E.L. Logigian Acute inflammatory demyelinating polyneuropathy: contribution of a dispersed compound muscle action potential to electrodiagnosis Muscle Nerve 33 2006 771 777
13. P.Y. Van den Bergh, R.D. Hadden, P. Bouche, D. Cornblath, A. Hahn, and I. Illa European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision Eur J Neurol 17 2010 356 363
14. European Federation of Neurological Societies, Peripheral Nerve Society, I.N. van Schaik, P. Bouche, I. Illa, and J.M. Léger European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy Eur J Neurol 13 2006 802 808
15. R. Voltz, F.V. Rosen, T. Yousry, J. Beck, and R. Hohlfeld Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin Neurology 46 1996 250 251
16. A.S. Wolberg, R.H. Kon, D.M. Monroe, and M. Hoffman Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations Am J Hematol 65 2000 30 34
17. D. Cocito, I. Paolasso, G. Antonini, L. Benedetti, C. Briani, and C. Comi Italian Network for CIDP Register. A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy Eur J Neurol 17 2010 289 294
18. K. Kimoto, M. Odaka, N. Yuki, and K. Hirata Complications with plasma exchange Risho Shinkeigaku 40 2000 1044 1046